Search

everythinglearnresearchcommunity

for

Search:↓

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

JAK inhibitors show promise for treating various skin diseases.

Minoxidil does not work to inhibit lysyl hydroxylases in newborn mouse lungs.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Nε-(carboxymethyl) lysine delays hair growth by blocking a key protein.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Minoxidil protects brain tissue directly, not by lowering blood pressure.

JAK inhibitors show promise in treating difficult skin diseases.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Minoxidil is a new drug that lowers blood pressure.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Developing microRNA-based treatments is hard but has potential.

New compounds may help treat heart disease by activating specific potassium channels.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

PEG and keratin scaffolds can effectively deliver protein drugs by controlling release based on pH levels.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.